Stock Earnings

Question 1

What are NLS Pharmaceutics AG's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Pfeiffer Vacuum Technology AG has a total asset of $1,036, Net profit of $37

Question 2

What are the key financial ratios for NLSP?

Accepted Answer

Pfeiffer Vacuum Technology AG's Current ratio is 2.17, has a Net margin is 4.18, sales per share of $89.58.

Question 3

How is NLS Pharmaceutics AG's revenue broken down by segment or geography?

Accepted Answer

Pfeiffer Vacuum Technology AG largest revenue segment is Analytics, Industry, Research & Development, at a revenue of 498,940,000 in the most earnings release.For geography, United States is the primary market for Pfeiffer Vacuum Technology AG, at a revenue of 233,365,000.

Question 4

Is NLS Pharmaceutics AG profitable?

Accepted Answer

yes, according to the latest financial statements, Pfeiffer Vacuum Technology AG has a net profit of $37

Question 5

Does NLS Pharmaceutics AG have any liabilities?

Accepted Answer

yes, Pfeiffer Vacuum Technology AG has liability of 476

Question 6

How many outstanding shares for NLS Pharmaceutics AG?

Accepted Answer

Pfeiffer Vacuum Technology AG has a total outstanding shares of 9.86

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	852	884	956	916	771	618
Revenue Growth (YoY)	-6%	-8%	4%	19%	25%	-2%
Cost of Revenue	539	565	599	587	490	401
Gross Profit	313	319	357	329	280	216
Selling, General & Admin	226	230	209	175	140	128
Research & Development	41	39	36	36	34	34
Operating Expenses	263	266	242	209	171	160
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	40	49	103	118	92	44
Income Tax Expense	9	12	26	32	30	12
Net Income	31	37	77	86	61	31
Net Income Growth	-49%	-52%	-10%	41%	97%	-35%
Shares Outstanding (Diluted)	9.86	9.86	9.86	9.86	9.86	9.86
Shares Change (YoY)	0%	0%	0%	0%	0%	0%
EPS (Diluted)	3.18	3.82	7.8	8.75	6.28	3.2
EPS Growth	-49%	-51%	-11%	39%	96%	-35%
Free Cash Flow	10	-5	13	-33	49	28
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	36.73%	36.08%	37.34%	35.91%	36.31%	34.95%
Operating Margin	5.86%	5.88%	11.92%	12.99%	14%	9.06%
Profit Margin	3.63%	4.18%	8.05%	9.38%	7.91%	5.01%
Free Cash Flow Margin	1.17%	-0.56%	1.35%	-3.6%	6.35%	4.53%
EBITDA	89	90	149	150	134	81
EBITDA Margin	10.44%	10.18%	15.58%	16.37%	17.38%	13.1%
D&A For EBITDA	39	38	35	31	26	25
EBIT	50	52	114	119	108	56
EBIT Margin	5.86%	5.88%	11.92%	12.99%	14%	9.06%
Effective Tax Rate	22.5%	24.48%	25.24%	27.11%	32.6%	27.27%

NLS Pharmaceutics AG (NLSP) Financial

NLSP Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is NLSP?

NLSP Income

Follow-Up Questions